Home/Filings/4/0000950170-25-022652
4//SEC Filing

Cuffe Michael S. 4

Accession 0000950170-25-022652

CIK 0000860730other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 7:30 PM ET

Size

6.7 KB

Accession

0000950170-25-022652

Insider Transaction Report

Form 4
Period: 2025-02-13
Cuffe Michael S.
EVP and Chief Clinical Officer
Transactions
  • Award

    Common Stock

    2025-02-13+2,33032,008.209 total
  • Tax Payment

    Common Stock

    2025-02-13$321.92/sh583$187,67931,425.209 total
Footnotes (1)
  • [F1]On January 28, 2022, the reporting person was granted 4,490 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Documents

1 file

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001632835

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:30 PM ET
Size
6.7 KB